The DEA banned a drug some opioid users called a miracle
Ars Technica ·
Researchers say the Schedule I ban could kill studies of a promising opioid treatment.
Researchers say the Schedule I ban could kill studies of a promising opioid treatment.
1 sources · 1 articles · updated 2026-11-04 15:08 UTC · health
Ars Technica ·
Researchers say the Schedule I ban could kill studies of a promising opioid treatment.